Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516833 | SCV000614984 | uncertain significance | not specified | 2016-10-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765120 | SCV000896342 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000765120 | SCV002026503 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002525074 | SCV003448782 | likely benign | Spastic paraplegia | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000765120 | SCV003820616 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2021-11-12 | criteria provided, single submitter | clinical testing | |
PROSPAX |
RCV000765120 | SCV005061956 | likely pathogenic | Charlevoix-Saguenay spastic ataxia | 2022-01-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV004691826 | SCV005192092 | uncertain significance | not provided | criteria provided, single submitter | not provided |